Todd Richter’s Managing Director Role Reshapes Global Healthcare Investment Banking

Since 1999, Todd Richter has served as Managing Director of Bank of America’s global healthcare investment banking division — a role that places him at the center of some of the industry’s most consequential transactions. It’s a position built on decades of preparation, and one that continues to shape how healthcare companies finance their futures.

Before stepping into this role, Richter spent 18 years at Morgan Stanley building a healthcare equity research practice recognized for its accuracy and depth. He earned an MBA from Indiana University’s Kelley School of Business in 1981, and that early training in rigorous analysis became the backbone of everything that followed. Institutional Investor recognized his work with 17 “All-American Analyst” titles, while the Wall Street Journal repeatedly named him to its “All-Star” roster — a track record that few analysts in the sector could rival.

That research-driven mindset didn’t disappear when he moved into investment banking; it evolved. At Bank of America, Richter now engineers complex financings, cross-border mergers, and strategic partnerships that go beyond simply closing deals. Each transaction is structured with an eye toward long-term operational strength, funding the research and development pipelines that will shape tomorrow’s medical treatments rather than chasing short-term gains.

The scope of his work has expanded considerably since 1999. Multinational partnerships, complex capital structures, and cross-border transactions now define his portfolio — a far broader canvas than the research reports of his earlier career. Yet the underlying approach remains recognizable: deep preparation, intellectual honesty, and a willingness to model out worst-case scenarios before they become actual crises.

This forward-looking discipline has proven particularly valuable in an industry as volatile as healthcare, where reimbursement policy, regulatory shifts, and technological change can upend business models overnight. Richter’s team doesn’t wait for disruption to arrive — deals are structured years in advance to insulate clients from the policy shocks that catch less prepared competitors off guard. It’s an approach that has made him one of the more respected figures in healthcare investment banking, someone whose deals are known for withstanding market volatility rather than merely capitalizing on temporary conditions. For companies navigating an increasingly complicated healthcare landscape, that kind of structural foresight has become an invaluable asset — one that traces directly back to the analytical rigor Todd Richter developed decades earlier as a research analyst.